Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Desenzano Del Garda

2 clinical trials in Desenzano Del Garda, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Desenzano Del Garda at a glance
2
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Desenzano Del Garda

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Ente Ospedaliero Ospedali Galliera Di Genova

Atrial fibrillation+2

Not recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Desenzano Del Garda

What the registry says about research in the country

01 Oncology Research

Investigating advanced treatments for low-grade serous epithelial ovarian cancer with a focus on hormone receptor-positive cases. The research evaluates the effectiveness of letrozole compared to standard chemotherapy treatments.

  • Ovarian Cancer Treatment
  • Hormone Therapy Evaluation
  • Progression-Free Survival Study

This research specifically targets patients with FIGO stage III-IV disease expressing estrogen or progesterone receptors.

02 Cardiovascular Medicine

Evaluating the efficacy of asundexian versus apixaban in preventing stroke and systemic embolism in patients with atrial fibrillation. The study focuses on both safety and effectiveness outcomes.

  • Stroke Prevention
  • Atrial Fibrillation Management
  • Bleeding Risk Assessment

Research aims to establish superior treatment options for patients at risk of stroke with atrial fibrillation.

03 Colorectal Cancer Research

Comparative study of treatment combinations for metastatic colorectal cancer, examining the effectiveness of bevacizumab versus cetuximab with chemotherapy in patients with specific genetic profiles.

  • Targeted Therapy Assessment
  • First-line Treatment Optimization
  • Biomarker-based Treatment Selection

Focus on personalizing treatment approaches based on RAS/BRAF mutation status using both tissue and liquid biopsy.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.